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Abstract
Mehrvarzfar P, Abbott PV, Saghiri MA, Delvarani A,
Asgar K, Lotfi M, Karamifar K, Kharazifard MJ, Khabazi
H. Effects of three oral analgesics on postoperative pain
following root canal preparation: a controlled clinical trial.
International Endodontic Journal, 45, 76–82, 2012.
Aim To compare the effects of single doses of three
oral medications on postoperative pain following
instrumentation of root canals in teeth with irreversible
pulpitis.
Methodology In this double-blind clinical trial, 100
patients who had anterior or premolar teeth with
irreversible pulpitis without any signs and symptoms of
acute or chronic apical periodontitis and moderate to
severe pain were divided by balanced block random
allocation into four groups of 25 each, a control group
receiving a placebo medication, and three experimental
groups receiving a single dose of either Tramadol
(100 mg), Novafen (325 mg of paracetamol, 200 mg
ibuprofen and 40 mg caffeine anhydrous) or Naproxen
(500 mg) immediately after the first appointment
where the pulp was removed, and the canals were
fully prepared. The intensity of pain was scored based
on 10-point VAS before and after treatment for up to
24 h postoperatively. Data were submitted to repeated
analysis of variance.
Results At the 6, 12 and 24 h postoperative inter-
vals after drug administration, the intensity of pain was
significantly lower in the experimental groups than in
the placebo group (P < 0.01). Tramadol was signifi-
cantly less effective (P < 0.05) than Naproxen, and
Novafen that were similar to each other (P > 0.05).
Conclusion A single oral dose of Naproxen, Novafen
and Tramadol taken immediately after treatment
reduced postoperative pain following pulpectomy and
root canal preparation of teeth with irreversible pulpi-
tis.
Keywords: endodontics, NSAIDs, pain, post-instru-
mentation pain.
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Introduction
One of the aims of root canal treatment is to prevent or
eliminate pain. Although dental procedures can be
performed without producing pain using local anaes-
thetics, postoperative pain is relatively common after
some procedures especially in patients with preopera-
tive pain (Albashaireh & Alnegrish 1998). Postopera-
tive pain following root canal treatment occurs because
of acute inflammation within the periradicular tissues
in response to an increase in the intensity of stimulants
coming from the root canal (Georgopoulou et al. 1986).
The prevalence of postoperative pain following root
canal treatment has been reported to be 3–58% (Ng
et al. 2004, Sathorn et al. 2008) although it varies
between studies and following different stages of the
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treatment. Some studies have reported mild pain after
chemo-mechanical preparation in about 10–30% of
cases (Georgopoulou et al. 1986, Siqueira et al. 2002),
and others have reported that the frequencies of
interappointment emergencies ranged from 1.4% to
16% (Morse et al. 1986, Trope 1990, Imura & Zuolo
1995, Siqueira et al. 2002). Furthermore, a positive
association has been demonstrated between postoper-
ative pain and the presence of apprehension and
preoperative pain (Morse et al. 1986, Torabinejad et al.
1994, Glennon et al. 2004).
Some drugs can prevent the production of inflamma-
tory mediators involved in producing pain, such as
prostaglandins owing to pulpal inflammation and
necrosis, and the corresponding periradicular tissue
changes (McNicholas et al. 1991). Prostaglandin tissue
levels are associated with patient reports of pain
(McNicholas et al. 1991, Nakanishi et al. 1995), and
therefore, nonsteroidal anti-inflammatory drugs (NSA-
IDs) may be key drugs for inflammatory pain abatement.
NSAIDs are widely available, and they have been
reported to be effective in managing endodontic pain
(Morse et al. 1990, Doroschak et al. 1999). Nonnarcotic
analgesics, NSAIDs and acetaminophen can all produce
analgesia; therefore, they can be effective for managing
pulp and periradicular pain (Roszkowski et al. 1997,
Holstein et al. 2002, Keiser &Hargreaves 2002). Several
double-blind, placebo-controlled trials in patients with
endodontic pain indicate that 400 mg of ibuprofen,
50 mg of ketoprofen, 100 mg of flurbiprofen and 30–
60 mg of ketorolac can all produce significant analgesia
when compared to placebos (Torabinejad et al. 1994,
Penniston & Hargreaves 1996, Keiser & Hargreaves
2002). Ibuprofen is one of the most frequently used
NSAIDs for control of postoperative pain associated with
root canal treatment, and it has good efficacy and safety
profiles (Dionne et al. 1983, Whitten et al. 1996,
Holstein et al. 2002, Dionne 2003). Naproxen is a
NSAID that inhibits the cyclooxygenase pathway, thus
preventing the release of inflammatory mediators such
as prostaglandins (Thun et al. 2002). Novafen is a
mixture of acetaminophen, ibuprofen and caffeine.
Acetaminophen affects the central and peripheral ner-
vous systems. Ibuprofen has anti-inflammatory effects
by inhibiting the synthesis of arachidonic acid metabo-
lites (Haas 2002). A suitable method for controlling
moderate to severe pain is to combine two or more drugs
so a lower dose of each drug is used with fewer side
effects. The combination of a NSAID and acetaminophen
has shown additive analgesia for treating dental pain in
several studies (Wright et al. 1983, Breivik et al. 1999,
Keiser & Hargreaves 2002). In cases not controlled by
this combination, a narcotic analgesic may also be given
for additional effects (Breivik et al. 1999, Wideman et al.
1999). Acetaminophen and ibuprofen are more effective
than ibuprofen alone in alleviating endodontic pain after
treatment, but surprisingly, no differences were detected
between ibuprofen and placebo (Menhinick et al. 2004).
As it may be possible to benefit from using lower
doses of NSAIDS with fewer side effects in combination
with acetaminophen to achieve better results compared
with higher doses of NSAIDS, the effects of Novafen and
Naproxen on postoperative endodontic pain were
evaluated. In addition, Tramadol, an opioid with CNS
effects, was used in comparison with NSAIDS, which
have mainly PNS effects (such as Naproxen), and
Novafen with a combined CNS and PNS effects as it is
important to take advantage of CNS and PNS effects
simultaneously. This study compared the effects of
single doses of these three oral medications on moder-
ate to severe postoperative pain following instru-
mentation of root canals in teeth with irreversible
pulpitis.
Materials and methods
Patients
One hundred patients participated in this double-blind,
placebo-controlled parallel design clinical trial that was
approved by the Committee of Ethics, Tehran Azad
University. Participants were selected consecutively
from patients referred to the Endodontic Department
of Tehran Azad University from 1 October to 27
November 2009; all were fully informed about the
investigation, and their written consent to participate
was received. The sample size was determined using the
results of a pilot study on 20 cases (five in each group)
(Table 1) by means of the one-way analysis of variance
formula for sample size determination for four groups
using Minitab Software (Minitab Inc., State College, PA,
USA) assuming alpha- and beta-errors at 0.05 level.
The inclusion criteria were as follows:
Patients were aged between 20 and 60 years with no
systemic diseases, and women were not pregnant;
Table 1 Results of the pilot study
Before drug 6 h
Naproxen 5.8 (5–7) 0.6 (0–1)
Novafen 6 (5–7) 0.6 (0–1)
Tramadol 5.6 (4–6) 3.2 (1–6)
Placebo 5.6 (5–7) 4.8 (4–6)
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No history of taking analgesics in the previous 12 h
or other drugs prior to presenting for treatment; and
Patients with moderate to severe spontaneous pain
associated with irreversible pulpitis in single-rooted
premolars or anterior teeth with no clinical or radio-
graphic signs or symptoms of acute or chronic apical
periodontitis.
Medical and dental histories were taken, and a
thorough clinical examination, including pulp sensibil-
ity testing, was carried out to diagnose the pulp status.
Irreversible pulpitis was defined by considering the
response of teeth to sensibility tests (thermal and EPT).
Patients with prolonged moderate to severe pain were
selected. All the patients had just one tooth with
irreversible pulpitis. Patients were divided randomly
into four groups of 25 patients each (Figure 1) – a
control group receiving a single dose of a placebo (a
starch containing capsule – Darou Pakhsh, Tehran,
Iran), and three experimental groups receiving either a
single dose of a Tramadol tablet (100 mg of Tramadol
hydrochloride; Tehran Darou Co., Tehran, Iran), Nova-
fen capsules [325 mg of paracetamol (acetaminophen)],
200 mg of ibuprofen and 40 mg of caffeine anhydrous
(Brown & Burk, Richmond, UK), or Naproxen tablets
(500 mg of naproxen, Pars Darou, Tehran, Iran),
immediately on completion of the first appointment
(Table 2). Balanced block random allocation was made
(12 blocks contained eight patients and one block
contained four patients) by generating random digits via
Microsoft Excel 2007 software (Microsoft Corporation,
Redmond, WA, USA). A nurse who was blinded to the
aim and the protocol of the study generated the
numbers. The intensity of the preoperative pain was
measured by instructing the patient to complete a Visual
Analogue Scale (VAS) (Torabinejad et al. 1994). The
markings on the VAS were measured, and the degree of
pain was categorized as mild (scores 1–3), moderate
(scores 4–6) or severe (scores 7–10).
Assessed for eligibility (n = 123)
Excluded  (n = 23)
♦ Not meeting inclusion criteria (n = 12)
♦ Declined to participate (n = 11)
♦ Other reasons (n = 0)Randomized (n = 100)
Allocated to intervention (n = 25)
♦Received allocated intervention 
(n = 25)
♦Did not receive allocated 
intervention (give reasons) 
(n = 0)
Allocated to intervention (n = 25)
♦Received allocated intervention 
(n = 25)
♦Did not receive allocated 
intervention (give reasons) 
(n = 0)
Allocated to intervention (n = 25)
♦Received allocated intervention 
(n = 25)
♦Did not receive allocated 
intervention (give reasons) 
(n = 0)
Allocated to intervention (n = 25)
♦ Received allocated 
intervention (n = 25)
♦Did not receive allocated 
intervention (give reasons) 
(n = 0)
Allocation
Lost to follow-up (give 
reasons) (n = 0)
Discontinued intervention 
(give reasons) (n = 0)
Lost to follow-up (give 
reasons) (n = 0)
Discontinued intervention 
(give reasons) (n = 0)
Lost to follow-up (give 
reasons) (n = 0)
Discontinued intervention 
(give reasons) (n = 0)
Lost to follow-up (give 
reasons) (n = 0)
Discontinued intervention 
(give reasons) (n = 0)
Analysed (n = 24)
♦ Excluded from analysis 
(give reasons) (n = 1 other 
drugs)
Analysed (n = 23)
♦ Excluded from analysis
(give reasons) (n = 2 other 
drugs)
Analysed (n = 24)
♦ Excluded from analysis 
(give reasons) (n = 1 other 
drugs)
Analysed (n = 24)
♦ Excluded from analysis 
(give reasons) (n = 1 other 
drugs)
Follow-Up
Analysis
Figure 1 Consort 2010 flow diagram of the trial.
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Intervention
After explanation of the treatment procedures, the
tooth was anaesthetized using one cartridge (1.8 mL)
of Persocaine-E (Lidocaine 2% plus epinephrine
1:80000; Darou Pakhsh Co, Tehran, Iran) local
anaesthetic solution. The teeth were considered anaes-
thetized when two consecutive negative responses to
electric pulp testing were achieved. If pain still
remained during access cavity preparation, intrapulpal
anaesthesia was used as supplementary anaesthesia.
All treatment was performed under rubber dam isola-
tion by one of the investigators (a general dentist). The
investigator who performed the root canal treatment
was blinded to the assignment. An access cavity was
prepared, and the working length was determined
electronically using an apex locator (Dentaport ZX; J.
Morita, Kyoto, Japan) 1 mm short of the apex with a
size 15 or 20 K-file and confirmed by periapical
radiographs. The apical part of each root canal was
prepared to a size 25 K-file with the step-back tech-
nique in a circumferential manner. Normal saline was
used as the irrigant solution between each instrument.
Canals were then dried with paper points, and the
access cavities were restored temporarily with Cavit
(3M ESPE, St Paul, MN, USA). Each patient’s tablet/
capsule was inserted into a sealed coded packet by a
trained person who was blinded to the drugs, and the
packet remained sealed until it was given to the patient.
The patients were supervised by one of the investigators
when taking the oral medications.
Assessment of pain experience following canal
preparation
A questionnaire containing the VAS was given to each
patient for them to record the intensity of pain felt after
6, 12 and 24 h. At the second appointment, 24 h later,
the root canal treatment was completed.
Statistics
Normal distribution was tested by the Kolmogorov–
Smirnov test. Data were analysed using repeated
measure analysis of variance considering baseline
VAS as a covariate and the intervention as the between
subject comparison. The alpha-level was adjusted at
0.05 for main effect, and adjusted Bonferroni correction
for multiple comparison data was analysed with SPSS
16 for windows (SPSS inc., Chicago, IL, USA). The
missing data were imputed by carrying the last
observation forward (LOCF).
Results
Two patients from the Novafen group and one patient
from the Tramadol, Naproxen and placebo groups took
additional analgesics and were excluded from the study
because of the homogeneity of the noncompliance
between groups and lack of the evidence of the severity
of pain amongst them. The number of noncompliance
samples was almost equal amongst the groups.
Table 2 Details of the medication under investigation
Medications Contents of the medication Manufacturer
Tramadol tablet 100 mg of tramadol hydrochloride Tehran Darou Co., Tehran, Iran
Novafen capsule 325 mg of paracetamol (acetaminophen),
200 mg ibuprofen and 40 mg caffeine anhydrous
Brown & Burk, Richmond, UK
Naproxen tablet 500 mg of naproxen Pars Darou, Tehran, Iran
Table 3 Demographic and baseline characteristics for each group
Naproxen
(n = 24)
Novafen
(n = 23)
Tramadol
(n = 24)
Placebo
(n = 24)
Age (years) 28.4 ± 7.6 29.6 ± 8.1 29.5 ± 6.9 31.4 ± 10.7
Gender
Male (%) 14 (58.3) 11 (47.8) 13 (54.2) 15 (62.5)
Female (%) 10 (41.7) 12 (52.2) 11 (45.8) 9 (37.5)
Tooth
Maxillary anterior (%) 11 (45.8) 12 (52.2) 10 (41.7) 13 (54.2)
Mandibular anterior (%) 3 (12.5) 3 (13) 4 (16.6) 2 (8.3)
Mandibular premolar (%) 10 (41.7) 8 (34.8) 10 (41.7) 9 (37.5)
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Otherwise, excluding the noncompliance samples was
not allowed.
The analysis was carried out on the VAS of 95 fully
compliant samples with baseline and demographic data
shown in Table 3. All patients reported postoperative
pain at the 12- and 24-h time intervals. In the 6-h
group, the samples with no response were replaced
using LOCF. Table 4 shows the mean and 95%
confidence intervals of the mean of VAS before and at
6, 12, and 24 h after drug administration. The
incidence of moderate to severe pain in the experimen-
tal groups was lower than that in the control group,
and this difference was significant (P < 0.01). In
addition, the mean intensity of pain in the experimental
groups was significantly lower than that of the control
group (P < 0.01). There was no significant difference
between Naproxen and Novafen (P > 0.05), but Tram-
adol was less effective than the other two drugs
(P < 0.05).
Discussion
This double-blind, placebo-controlled parallel design
clinical trial compared the analgesic effects of three
different drugs with those of a placebo under controlled
clinical conditions. However, it is recognized that
eliminating the placebo effect can produce some bias
in the results (Torabinejad et al. 1994). Only patients
with moderate to severe pain were selected for two
reasons: first, controlling this type of pain is challeng-
ing for clinicians and, secondly, because the greatest
predictor for postoperative pain intensity is the severity
of preoperative pain (O’Keefe 1976). Double-blind drug
administration and the elimination or matching of
other variables can lead to increased internal validity
and more precise results. Patient cooperation and
relying on their answers to a questionnaire are other
potential problems associated with these types of
studies.
The effects of the drugs were assessed for up to 24 h
after treatment whereas some other studies have only
assessed the effects of drugs for up to 8 h (Jung et al.
2004, Menhinick et al. 2004). Most patients experience
pain in the first 24 h after root canal treatment
(Torabinejad et al. 1994), and therefore, this longer
period for assessment was chosen even though the drugs
tested would not be expected to provide ongoing
analgesia for this entire period owing to their relatively
short plasma half-lives, which is much less than 24 h
(McVerry et al. 1986, Dayer et al. 1997). After some
time and inflammation reduction, the pain intensity
would be expected to decrease. The administration of
Tramadol, and especially Novafen and Naproxen, is
likely to speed up the reduction of pain resulting
from inflammation because of their anti-inflammatory
effects.
To evaluate just the effect of drugs and achieve better
control of the interfering factors, normal saline was
used as the root canal irrigant instead of sodium
hypochlorite. Even a dilute solution of sodium hypo-
chlorite can cause untoward reactions and pain if
injected periapically or exposed to the oral tissues. Also,
intracanal medicaments such as calcium hydroxide
may have some effects on post-instrumentation pain
(Rosenberg 2002), and no intracanal medicament was
used. As the pulps were vital prior to root canal
treatment and the procedure was performed under
aseptic condition, intracanal medications such as
calcium hydroxide seem to provide no further benefits
for 24 h prior to filling of the root canals.
Patients with irreversible pulpitis without apical
periodontitis were selected for this study. They usually
respond well to a pulpectomy, which can eliminate the
primary cause of the symptoms, thereby reducing the
pain (as can be seen in the placebo group). Therefore, it
is likely that effective pain relief may result from this
procedure and by administering a single dose of an
analgesic drugs.
Patients with no history of taking analgesics in the
previous 12 h or other drugs prior to presenting for
treatment were selected to eliminate the interfering
effects of these other agents. Also, variables such as the
patient’s metabolism, gastrointestinal condition may
affect the effective therapeutic dose of drugs in each
individual. Further studies should consider these vari-
ables.
The results demonstrated that a single oral dose of a
Tramadol tablet, a Novafen capsule or a Naproxen
tablet immediately after root canal preparation,
reduced the intensity of postoperative pain. Different
doses of Tramadol (Collins et al. 1997) as well as
Naproxen (Gottesdiener et al. 1999) can effectively
Table 4 The means and their 95% confidence intervals of the
mean (in parenthesis) of VAS before and after administration
of the experimental or placebo drugs
Before drug 6 h 12 h 24 h
Naproxen 5.8 (4.9–6.7) 0.8 (0.3–1.2) 0.5 (0.3–.7) 0.7 (0.3–1.1)
Novafen 5.8 (4.6–6.9) 0.6 (0.2–1.0) 0.7 (0.2–1.2) 0.4 (0.1–.8)
Tramadol 5.1 (4.2–6.0) 3.2 (2.1–4.3) 2.1 (1.5–2.7) 2.2 (1.2–3.1)
Placebo 5.7 (4.9–6.5) 4.8 (3.5–6.2) 3.7 (3.1–4.3) 3.2 (2.6–3.9)
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reduce the intensity of pain after third molar surgery.
The results of these two studies are in agreement with
the results of the current study.
The combination of a NSAID with other analgesics
such as acetaminophen and Tramadol can reduce
moderate to severe endodontic pain more effectively
than single medications (Holstein et al. 2002). The
combination of acetaminophen and ibuprofen has been
shown to be more effective in reducing pain after root
canal treatment (Menhinick et al. 2004), and a com-
bination of acetaminophen, ibuprofen and codeine has
been found to reduce acute pain after third molar
surgery more than a combination of Tramadol and
acetaminophen (Jung et al. 2004). Similarly, in the
present study, Novafen (a mixture of acetaminophen,
ibuprofen and caffeine) was effective in reducing
postoperative pain.
The NSAIDs inhibit the production of inflammatory
mediators; thus, they reduce pain, especially moderate
to severe pain after root canal treatment (Madison &
Anderson 1992). Opioids have the ability to affect the
pain threshold and pain perception (Schnitzer 2003).
In the present study, Tramadol could not produce as
effective analgesia as the other two drugs. A combina-
tion of ibuprofen and acetaminophen appears to be a
suitable choice for alleviating moderate to severe pain
after endodontic treatment or surgery. However, only
the effects of these drugs on pain were evaluated in this
study and not the adverse effects; thus, it is not possible
to assess the risk to benefit ratio of using these drugs in
this manner.
Conclusion
A single oral dose of NSAID drugs such as Naproxen
and Novafen immediately after root canal preparation
relieved postoperative pain more than Tramadol or a
placebo when there was moderate to severe preopera-
tive pain associated with irreversible pulpitis, in the first
24 h after treatment.
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